Plans to open new R&D lab

Scroll Down

“We are extremely grateful to the City of Fishers and to the IEDC for making Fishers a supportive place to grow our business,” said Bill Vincent, CEO of Genezen. “Gene and cell therapies have shown amazing potential in treating cancer and rare genetic disorders, but manufacturing capacity has proven to be a bottleneck in advancing these therapies to help patients. Genezen’s expansion will not only help alleviate this challenge but will provide an anchor for developing other gene therapy and biotech companies in central Indiana.

See the full story on Inside Indiana Business.

You may also be interested in...

Genezen completes cGMP-lentiviral and retroviral vector…

Genezen, a cell and gene therapy Contract Development and Manufacturing Organization...

Read more

Genezen announces launch of Scientific Advisory…

Leading experts in cell and gene therapy will provide guidance to...

Read more

Overcoming development and manufacturing challenges with…

As efficient and effective tools for gene transduction and delivering genes...

Read more

Retroviruses in CAR-T therapies: From gamma…

Introduction In recent years, chimeric antigen receptor T (CAR-T) cells have...

Read more